The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Εμφάνιση άλλων εκδόσεων (1)

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
Μορφή:	Conference item
Έκδοση:	Springer London 2018

Παρόμοια τεκμήρια

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
ανά: Ali, M, κ.ά.
Έκδοση: (2018)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
ανά: Ali, MS, κ.ά.
Έκδοση: (2017)

Oral bisphosphonates and chronic kidney disease: progression and safety
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
ανά: Alarkawi, D, κ.ά.
Έκδοση: (2018)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
ανά: Robinson, DE, κ.ά.
Έκδοση: (2021)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
ανά: Strauss, V, κ.ά.
Έκδοση: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
ανά: Robinson, DE, κ.ά.
Έκδοση: (2021)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
ανά: Robinson, DE, κ.ά.
Έκδοση: (2021)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
ανά: Alarkawi, D, κ.ά.
Έκδοση: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
ανά: Ali, M, κ.ά.
Έκδοση: (2017)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
ανά: Danielle E Robinson, κ.ά.
Έκδοση: (2021-03-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
ανά: Veronika Kreutle, κ.ά.
Έκδοση: (2014-06-01)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
ανά: Hawley, S, κ.ά.
Έκδοση: (2014)

Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
ανά: Ryan Jalleh, κ.ά.
Έκδοση: (2018-01-01)

Denosumab and chronic kidney disease: Severe life-threatening hypocalcaemia
ανά: Pilar Monge Rafael, κ.ά.
Έκδοση: (2018-01-01)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2014)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
ανά: Ali, MS, κ.ά.
Έκδοση: (2020)

Patients With atypical femur fractures have the same mortality as the background population--drug-dhanneling bias, bisphosphonate effects, and public health implications
ανά: Abrahamsen, B, κ.ά.
Έκδοση: (2016)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
ανά: Oda, T, κ.ά.
Έκδοση: (2021)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
ανά: Round, G, κ.ά.
Έκδοση: (2012)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
ανά: Round, G, κ.ά.
Έκδοση: (2012)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
ανά: Reyes, C, κ.ά.
Έκδοση: (2015)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2012)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
ανά: Jean-Jacques Body, κ.ά.
Έκδοση: (2018-09-01)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density
ανά: Rodriguez, AJ, κ.ά.
Έκδοση: (2020)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
ανά: Garriga, C, κ.ά.
Έκδοση: (2017)

Vitamin D repletion and aromatase inhibitor-related bone loss in women non treated with bisphosphonates
ανά: Prieto-Alhambra, D, κ.ά.
Έκδοση: (2011)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
ανά: Khalid, S, κ.ά.
Έκδοση: (2021)

HYPOCALCAEMIA – CASE REPORT
ανά: Tina Svetlik, κ.ά.
Έκδοση: (2022-03-01)

Pseudohypoparathyroidism, Rare Cause of Hypocalcaemia!
ανά: Rupal V. Dosi, κ.ά.
Έκδοση: (2013-10-01)